#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Functional Integrity of Neural Retina in 2. Type Diabetics


Authors: N. Beszédešová 1;  E. Budinská 2;  Š. Skorkovská 1
Authors place of work: Klinika nemocí očních a optometrie, LF MU a FN u sv. Anny, Brno, přednosta doc. MUDr. Svatopluk Synek, CSc. 1;  Institut biostatistiky a analýz, PřF a LF MU, Brno, ředitel doc. RNDr. Ladislav Dušek, PhD. 2
Published in the journal: Čes. a slov. Oftal., 65, 2009, No. 4, p. 124-130

Summary

The purpose of this prospective longitudinal study was to investigate early defects in functional integrity of neural retina in 2. type diabetic patients without or with mild diabetic retinopathy (DR) since there is an evidence of early functional changes in neural retina before occurrence of clinical manifestation of DR. Psychophysical test of contrast sensitivity (CS) was used for the detection of these changes. Relation between CS and systemic risk factors (HbAlc, blood pressure (BP), serum lipids and BMI) were also evaluated during a follow-up time.

There were 48 recent diabetics without DR included in this study that were examined 3 times and compared to 23 diabetics with mild DR. The CS tests were performed using both Sine Wave Contrast Test (SWCT) and Pelli-Robson (PR) test. The reference values for CS threshold were derived from a CS of a control group of 52 healthy individuals.

Abnormal CS ascertained by both methods, SWCT and PR, was observed in diabetics with mild NPDR. In comparison to the control group, there was a statistically significant difference of CS in spatial frequencies (SF) of 1.5, 6, 12, 18 cycles per degree (cy/deg). In comparison to diabetics without DR there was a significant difference of CS in SF of 6, 12 and 18 cy/deg in diabetics with mild NPDR. Abnormal CS was noticed in 47.8% (SWCT) or 21.7% (PR) of diabetics with DR. Statistically significant influence of high systolic BP on CS values and visual acuity was noticed. There were no abnormalities in CS in patients without DR comparing to control group during the whole follow-up. However, there was an improvement of CS in SF of 18 cy/deg observed between 1. and 3. evaluation of CS. Interaction of change in values of HbA1c and total cholesterol to HDL ratio had significant influence on CS improvement. Diabetics without DR had significantly better diabetes and blood pressure control in comparison to the diabetics with DR.

In conclusion, it was not proved in this study that CS test is suitable for the screening for DR or early functional defects in neural retina before clinical manifestation of DR. Early diagnosis of DM and good compensation of diabetes, blood pressure and serum lipids level can postpone the onset of DR as well as the visual functions impairments.

Key words:
2. type diabetics, diabetic retinopathy, neural retina, contrast sensitivity, systemic risk factors


Zdroje

1. Antonetti, D. A., Barber, A. J., Bronson, S. K. et al.: Diabetic retinopathy: seeing beyond glucose-induced microvascular disease. Diabetes, 2006; 55: 2401–2411.

2. Arden G. B.: Visual loss in patients with normal visual acuity. Trans. Ophthalmol. Soc. UK, 1978; 98: 219–231.

3. Arditi, A.: Improving the design of the letter contrast sensitivity test. Invest. Ophthalmol. Vis. Sci., 2005; 46: 2225–2229.

4. Brinchmann-Hansen, O., Bangstad, H. J., Hultgren, S. et al.: Psychophysical visual function, retinopathy, and glykemic control in insulin-dependent diabetics with normal visual acuity. Acta Ophthalmologica, 1993; 71: 230–257.

5. Chihara, E., Matsuoka, T., Ogura, Y. et al.: Retinal nerve fibre layer defect as an early manifestation of diabetic retinopathy. Ophthalmology, 100, 1993; 8: 1147–1151.

6. De Marco R., Capasso, L., Magli, A. et al.: Measuring contrast sensitivity in aretinopathic patients with Insulin Dependent Diabetes Mellitus. Documenta Ophthalmologica, 1997; 93: 199–209.

7. Della Sala, S., Bertoni, G., Somazzi, L. et al.: Impaired contrast sensitivity in diabetic patients with and without retinopathy, a new technique for rapid assessment. Br. J. Ophthalmol., 1985; 69: 136-142.

8. Dosso, A. A., Bonvin, E. R., Morel, Y. et al.: Risk factors associated with contrast sensitivity loss in diabetic patients. Graefe’s Arch. Clin. Exp. Ophthalmol., 1996; 234: 300–305.

9. Ghafour, I. M., Foulds, W. S., Allan, D. et al.: Contrast sensitivity in diabetic subjects with and without retinopathy. Br. J. Ophthalmol., 1982; 66: 492–495.

10. Hyvärinen, L., Laurinen, P., Rovamo, J.: Contrast sensitivity in evaluation of visual impairment due to diabetes. Acta Ophthalmol., 1983; 61: 94–101.

11. Ismail, G. M., Whitaker, D.: Early detection of changes in visual function in diabetes mellitus. Ophthal. Physiol. Opt., 18, 1998; 1: 3–12.

12. Krásný, J., Brunnerová, R., Průhová, Š. et al.: Test citlivosti na kontrast v časné detekci očních změn u dětí, dospívajících a mladých dospělých s diabetes mellitus 1. typu. Čes. a slov. Oftal., 62, 2006; 6: 381–394.

13. Krásný, J., Cihelková, I., Domínek, Z. et al.: Citlivost na kontrast a fluorescenční angiografie při hodnocení očních změn v rámci posouzení kompenzace diabetes mellitus 1. typu u mladých dospělých pacientů. Čes. a slov. Oftal., 63, 2007; 1: 17–27.

14. Lieth, E., Gardner, T. W., Barber, A. J. et al.: Retinal neurodegeneration: early pathology in diabetes. Clinical and Experimental Ophthalmology, 2000; 28: 3–8.

15. Liška, V.: Funkce citlivosti na kontrast u diabetiků I. typu (IDDM) bez známek diabetické retinopate. Čes. a slov. Oftal., 55, 1999; 4: 237–245.

16. Mackie S. W., Walsh G.: Contrast and glare sensitivity in diabetic patients with and without pan-retinal photocoagulation. Ophthalmic Physiol. Opt., 18, 1998; 2: 173–81.

17. North, R. V., Farrell, U., Banford, D. et al.: Visual function in young IDDM patients over 8 years of age. A 4-year longitudinal study. Diabetes care, 20, 1997; 11: 1724–1730.

18. R Development Core Team (2007). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, URL http://www.R-project.org.

19. Reiter, C. E. N., Wu, X., Sandirasegarane, L. et al.: Diabetes reduces basal retinal insulin receptor signaling: reversal with systemic and local insulin. Diabetes, 2006; 55: 1148–1156.

20. Sokol, S., Moskowitz, A., Skarf, B. et al.: Contrast sensitivity in diabetics with and without background retinopathy. Arch. Ophthalmol., 103, 1985: 51–54.

21. StatSoft, Inc. (2005). STATISTICA Cz [Softwarový systém na analýzu dat], verze 7.1. Www.StatSoft.Cz.

22. Stavrou, E. P., Wood, J. M.: Letter contrast sensitivity changes in early diabetic retinopathy. Clin. Exp. Optom., 86, 2003; 3: 152–156.

Štítky
Ophthalmology
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#